Home › Bronchiolitis Obliterans Syndrome › Ohio › Columbus
Bronchiolitis Obliterans Syndrome clinical trials in Columbus, OH
5 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
- The Ohio State University, Columbus
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
RecruitingObservational study
- The Ohio State University Wexner Medical Center, Columbus
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Ohio State University, Columbus
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Tampa, FL6 studies
- Baldwin Park, CA6 studies
- Durham, NC6 studies
- Washington, DC6 studies
- Philadelphia, PA6 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.